Summary
After listing at ₹880 on Aug 6, NSDL rallied to ~₹1,425 within four sessions before profit‑taking; near‑term P/E ~77–79 vs peer CDSL ~66, so momentum may pause into the Aug 12 results.
Chart Thesis
Structure: Parabolic advance from ₹880 to ₹1,425, followed by intraday rejection—first meaningful pullback likely to set a higher low above ₹1,200 if the trend is to continue.
Levels:
Long zone: ₹1,200–₹1,250
Invalidation: Close <₹1,160
Targets: ₹1,360 → ₹1,400–₹1,425
Note: Event risk—board meets Aug 12 to consider Q1 FY26; expect swings.
Fundamentals
FY25 revenue +~12% to ₹1,420–1,535cr; PAT ₹343cr (+~25% YoY); near‑duopoly advantages but valuation now full post‑rally.
Plan
Avoid chasing strength; buy dips only with tight risk and take partials near prior highs. Investors with IPO gains can book some profits and hold a core for the long term.
Disclaimer: Educational, not investment advice. Manage risk.
After listing at ₹880 on Aug 6, NSDL rallied to ~₹1,425 within four sessions before profit‑taking; near‑term P/E ~77–79 vs peer CDSL ~66, so momentum may pause into the Aug 12 results.
Chart Thesis
Structure: Parabolic advance from ₹880 to ₹1,425, followed by intraday rejection—first meaningful pullback likely to set a higher low above ₹1,200 if the trend is to continue.
Levels:
Long zone: ₹1,200–₹1,250
Invalidation: Close <₹1,160
Targets: ₹1,360 → ₹1,400–₹1,425
Note: Event risk—board meets Aug 12 to consider Q1 FY26; expect swings.
Fundamentals
FY25 revenue +~12% to ₹1,420–1,535cr; PAT ₹343cr (+~25% YoY); near‑duopoly advantages but valuation now full post‑rally.
Plan
Avoid chasing strength; buy dips only with tight risk and take partials near prior highs. Investors with IPO gains can book some profits and hold a core for the long term.
Disclaimer: Educational, not investment advice. Manage risk.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.